Literature DB >> 4256557

Modification of the action of pancuronium by succinylcholine and halothane.

R L Katz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4256557     DOI： 10.1097/00000542-197112000-00009

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  7 in total

Review 1.  Safety considerations in the use of drug combinations during general anaesthesia.

Authors:  E S Ransom; R A Mueller
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

2.  The rational use of neuromuscular blocking agents: the role of pancuronium.

Authors:  F F Foldes
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 3.  Pancuronium bromide: a review of its pharmacological properties and clinical application.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 4.  Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  M Abel; W J Book; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 5.  Clinical pharmacokinetics of the non-depolarising muscle relaxants.

Authors:  M I Ramzan; A A Somogyi; J S Walker; C A Shanks; E J Triggs
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

6.  Neuromuscular effects of pipecuronium during sevoflurane anesthesia compared with isoflurane and enflurane anesthesia.

Authors:  Y Nakao; M Ohno; M Imai; O Kemmotsu
Journal:  J Anesth       Date:  1993-10       Impact factor: 2.078

7.  Interaction of halothane with non-depolarizing neuromuscular blocking drugs in man.

Authors:  R Hughes; J P Payne
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.